Lupartumab (BAY 1112623) is an anti-LYPD3 (C4.4A) monoclonal antibody that can be used to synthesize antibody-active molecular couplers that can be used to study LYPD3-associated tumor diseases.
CAS Number:
[1640971-88-5]
Target:
BAY 1112623
* VAT and and shipping costs not included. Errors and price changes excepted